Literature DB >> 8445745

In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study.

N L'Heureux1, L Germain, R Labbé, F A Auger.   

Abstract

PURPOSE: The purpose of this study was to create a tubular vascular model exclusively made of human cells and collagen.
METHODS: The blood vessel equivalent was constructed with the three following human cell types: vascular smooth muscle cells, endothelial cells, and fibroblasts. A tissuelike structure was obtained from the contraction of a tubular collagen gel (human origin) by vascular smooth muscle cells, which created a media-like structure. An adventitia-like tissue was added around the media-like structure by embedding fibroblasts into a collagen gel. An endothelium was established within the tubular structure after intraluminal cell seeding.
RESULTS: Cell orientation and gel contraction were followed up over time. Vascular smooth muscle cells developed a complex tridimensional network and were oriented in a circular fashion around the tube's axis. In contrast, fibroblasts were randomly oriented. A viable, homogeneous, and well-characterized endothelium was observed. These endothelial cells showed a slightly elongated structure and were oriented parallel to this vascular equivalent axis.
CONCLUSION: An in vitro tridimensional vascular model that exhibits some phenotypic characteristics of in vivo vascular cells could be useful in the study of events that lead to atherosclerotic plaque formations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445745     DOI: 10.1067/mva.1993.38251

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  52 in total

Review 1.  Tissue engineering of the vascular system: from capillaries to larger blood vessels.

Authors:  L Germain; M Rémy-Zolghadri; F Auger
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

2.  Fibrin degradation enhances vascular smooth muscle cell proliferation and matrix deposition in fibrin-based tissue constructs fabricated in vitro.

Authors:  Katherine A Ahmann; Justin S Weinbaum; Sandra L Johnson; Robert T Tranquillo
Journal:  Tissue Eng Part A       Date:  2010-10       Impact factor: 3.845

Review 3.  Designer blood vessels and therapeutic revascularization.

Authors:  Joseph D Berglund; Zorina S Galis
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

Review 4.  Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly.

Authors:  Chris A Bashur; Lavanya Venkataraman; Anand Ramamurthi
Journal:  Tissue Eng Part B Rev       Date:  2012-03-02       Impact factor: 6.389

5.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

6.  Tubular hydrogels of circumferentially aligned nanofibers to encapsulate and orient vascular cells.

Authors:  Mark T McClendon; Samuel I Stupp
Journal:  Biomaterials       Date:  2012-05-14       Impact factor: 12.479

7.  Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization.

Authors:  John J Stankus; Lorenzo Soletti; Kazuro Fujimoto; Yi Hong; David A Vorp; William R Wagner
Journal:  Biomaterials       Date:  2007-02-20       Impact factor: 12.479

Review 8.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

Review 9.  Biomaterials for vascular tissue engineering.

Authors:  Swathi Ravi; Elliot L Chaikof
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

10.  Vascular endothelial growth factor overexpression increases vascularization by murine but not human endothelial cells in cultured skin substitutes grafted to athymic mice.

Authors:  Dorothy M Supp; Andrea C Karpinski; Steven T Boyce
Journal:  J Burn Care Rehabil       Date:  2004 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.